Inicio > FERNANDEZ SALAZAR, LUIS IGNACIO

FERNANDEZ SALAZAR, LUIS IGNACIO

PROFESORES TITULARES DE UNIVERSIDAD
Medicina, Dermatología y Toxicología
Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
 
luisignacio.fernandez@uva.es

Índice H en Scopus: 26
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80267]], camposKey:0017-5749 2023-11-01 Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)20312037, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80268]], camposKey:2077-0383 2023-07-01 Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80269]], camposKey:0017-5749 2023-06-01 Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)10541072, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76230]], camposKey:0210-5705 2023-02-01 Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study Incidencia e historia natural de la enfermedad inflamatoria intestinal en Castilla y León: estudio prospectivo, multicéntrico y poblacional102108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80271]], camposKey:0004-2803 2023-01-01 Early-onset colorectal cancer: an eleven-year analysis of clinicopathological characteristics at a tertiary healthcare center Câncer colorretal de início precoce: uma análise de onze anos das características clinicopatológicas em um centro de saúde terciário315321, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80272]], camposKey:1130-0108 2023-01-01 Esophageal epidermoid metaplasia. An unusual finding192193, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78904]], camposKey:0210-5705 2023-01-01 Incidencia e historia natural de la enfermedad inflamatoria intestinal en Castilla y León: estudio prospectivo, multicéntrico y poblacional102108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76231]], camposKey:0210-5705 2023-01-01 Influence of enlarged waist circumference and hypertriglyceridemia in the severity of acute pancreatitis: A retrospective study Influencia del aumento de la circunferencia de la cintura y la hipertrigliceridemia en la gravedad de la pancreatitis aguda: un estudio retrospectivo00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78859]], camposKey:2340-4167 2023-01-01 Metaplasia epidermoide de esófago: Un hallazgo inusual194195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80270]], camposKey:2050-6406 2023-01-01 Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76232]], camposKey:2077-0383 2022-10-01 Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75351]], camposKey:1542-3565 2022-10-01 Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)22432257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76233]], camposKey:2077-0383 2022-09-01 Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76234]], camposKey:2077-0383 2022-06-01 Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75235]], camposKey:0210-5705 2022-05-01 V Spanish Consensus Conference on Helicobacter pylori infection treatment392417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76235]], camposKey:2296-858X 2022-02-01 Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66500]], camposKey:0192-0790 2022-02-01 Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78903]], camposKey:2340-4167 2022-01-01 Guías sobre Helicobacter pylori de 2021. Coincidencias y divergencias de las guías española y de la Organización Mundial de Gastroenterología (OMG)129132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70627]], camposKey:0210-5705 2022-01-01 Hepatitis colestásica como forma de presentación de sífilis secundaria1819, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71441]], camposKey:1873-9946 2022-01-01 Human intestinal CD103+SIRP alpha plus conventional dendritic cells from patients with Crohn's disease prime IL-17+T-cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71439]], camposKey:1873-9946 2022-01-01 Intravenous ustekinumab as maintenance treatment is effective in patients with partial or loss of response to optimized ustekinumab sc00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71442]], camposKey:1873-9946 2022-01-01 Low Risk of new dysplastic lesions during inflammatory bowel disease surveillance with dye-cromoendoscopy: a multicenter population-based retrospective study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71440]], camposKey:1873-9946 2022-01-01 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69922]], camposKey:0210-5705 2022-01-01 Schwannoma gástrico. Diagnóstico diferencial de tumores submucosos5859, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70599]], camposKey:0210-5705 2022-01-01 Tratamiento endoscópico de la perforación mediante Padlock Clip®, a propósito de 2 casos99100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70626]], camposKey:0210-5705 2022-01-01 V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori392417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71444]], camposKey:1130-0108 2022-01-01 2021 Guidelines on Helicobacter pylori. Coincidences and divergences between the Spanish and World Gastroenterology Organisation (WGO) guidelines129132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66501]], camposKey:1130-0108 2021-10-01 Clinical practice guidelines. v spanish consensus conference on helicobacter pylori infection treatment740763, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71448]], camposKey:2079-6382 2021-08-01 The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66502]], camposKey:1130-0108 2021-07-01 Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients512518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66503]], camposKey:0002-9270 2021-06-01 Adverse Event Profile during the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients from the European Registry on H. pylori Management (Hp-EuReg)12201229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71446]], camposKey:1873-9946 2021-05-01 Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71450]], camposKey:0002-9270 2021-05-01 Persistent Villous Atrophy in De Novo Adult Patients With Celiac Disease and Strict Control of Gluten-Free Diet Adherence: A Multicenter Prospective Study (CADER Study)10361043, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71445]], camposKey:1873-9946 2021-05-01 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71447]], camposKey:1130-0108 2021-01-01 A rare case of emphysematous gastritis caused by Lactobacillus fermentum in a patient with diabetes COMMENT671671, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66504]], camposKey:0210-5705 2021-01-01 Cholestatic hepatitis as a presentation of secondary syphilis Hepatitis colestásica como forma de presentación de sífilis secundaria00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66184]], camposKey:0210-5705 2021-01-01 Endoscopic treatment of perforation using a Padlock Clip®: 2 case reports Tratamiento endoscópico de la perforación mediante Padlock Clip®, a propósito de 2 casos00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71449]], camposKey:1130-0108 2021-01-01 Esophageal involvement in a patient with pemphigus vulgaris297297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71453]], camposKey:2079-6382 2021-01-01 European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=62655]], camposKey:0210-5705 2021-01-01 Gastric schwannoma. Differential diagnosis of submucosal tumours Schwannoma gástrico. Diagnóstico diferencial de tumores submucosos00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71452]], camposKey:1130-0108 2021-01-01 Influence of the onset of the SARS-CoV-2 pandemic on the diagnosis and treatment of ulcerative colitis1510, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71455]], camposKey:1130-0108 2021-01-01 Ischemic skin necrosis secondary to the use of terlipressin6170, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64751]], camposKey:1130-0108 2021-01-01 Prevalencia y factores asociados a la mala calidad del sueño en pacientes con enfermedad inflamatoria intestinal no hospitalizados512518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66183]], camposKey:0954-691X 2021-01-01 Should the birth month be considered as one of the possible environmental risk factors in the pathogenesis of inflammatory bowel disease?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64752]], camposKey:1130-0108 2021-01-01 V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori740764, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66505]], camposKey:1130-0108 2021-01-01 Villous atrophy persistence in celiac disease despite following a gluten-free diet must be clarified00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71457]], camposKey:1873-9946 2020-04-01 Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients480489, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71456]], camposKey:1130-0108 2020-01-01 Acute phlegmonous esophagitis: apropos of a case COMMENTARY806806, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56280]], camposKey:1083-4389 2020-01-01 Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52746]], camposKey:1613-4125 2020-01-01 Circulating Dendritic Cells from Celiac Disease Patients Display a Gut-Homing Profile and are Differentially Modulated by Different Gliadin-Derived Peptides00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52747]], camposKey:1078-0998 2020-01-01 Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52761]], camposKey:1130-0108 2020-01-01 Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56278]], camposKey:1078-0998 2020-01-01 Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry606616, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71454]], camposKey:1130-0108 2020-01-01 Gastrointestinal and renal involvement in systemic vasculitis COMMENTARY953953, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56277]], camposKey:1083-4389 2020-01-01 Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56279]], camposKey:0210-5705 2020-01-01 Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab Púrpura trombocitopénica inmune asociada a colitis ulcerosa inactiva en tratamiento crónico con adalimumab2829, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71458]], camposKey:1083-4389 2019-09-01 Efficacy of first-line regimens in Spain: Results from the European Registry on H. pylori management (Hp-EuReg)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71459]], camposKey:2364-3722 2019-06-01 Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71460]], camposKey:1873-9946 2019-03-01 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56283]], camposKey:1078-0998 2019-01-01 Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results from the ENEIDA Registry18621870, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56285]], camposKey:0210-5705 2019-01-01 An unexpected finding of cat scratch colon in a screening colonoscopy Hallazgo inesperado de colon en arañazo de gato en una colonoscopia de cribado172173, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56282]], camposKey:1130-0108 2019-01-01 Cat scratch esophagus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56281]], camposKey:1873-9946 2019-01-01 Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study14921500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49115]], camposKey:0269-2813 2019-01-01 Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU419428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56286]], camposKey:1130-0108 2019-01-01 Eosinophilic esophagitis after an episode of herpetic esophagitis4060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56287]], camposKey:0009-7411 2019-01-01 Neuroendocrine tumor associate with inflammatory bowel disease: Two cases report Tumor neuroendocrino relacionado con enfermedad inflamatoria intestinal: A propósito de dos casos1721, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56393]], camposKey:0269-2813 2019-01-01 Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry278288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56284]], camposKey:1130-0108 2019-01-01 Treating Helicobacter pylori infection in the face of growing antibiotic resistance653654, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71462]], camposKey:0213-1463 2018-04-01 GASTROENTEROLOGIC OUTPATIENT CLINIC AND COMMUNICATION WITH PRIMARY CARE UNITS. MUCH ROOM FOR IMPROVEMENT3031, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56289]], camposKey:0269-2813 2018-03-01 Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study605614, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71466]], camposKey:1873-9946 2018-02-01 Differential characteristics of patients with inflammatory bowel disease onset in paediatric age compared with patients diagnosed in adulthood: Results from the CAROUSEL study of GETECCU00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71467]], camposKey:1873-9946 2018-02-01 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71464]], camposKey:1873-9946 2018-02-01 Interstitial and granulomatous lung disease in inflammatory bowel disease patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71465]], camposKey:1873-9946 2018-02-01 Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71463]], camposKey:1873-9946 2018-02-01 Prevalence of viral hepatitis in patients with IBD: A multi-centre and population-based study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43876]], camposKey:1130-0108 2018-01-01 Evaluación mediante las redes sociales de la información con la que cuentan los pacientes con EII274284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56288]], camposKey:0002-9270 2018-01-01 Long-term safety of in utero exposure to anti-TNF¿ drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study396403, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56357]], camposKey:0210-5705 2018-01-01 Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients [Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asoci118127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56291]], camposKey:1873-9946 2018-01-01 Serial tuberculin skin tests improve the detection of latent tuberculosis infection in patients with inflammatory bowel disease12701279, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56290]], camposKey:1130-0108 2018-01-01 Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information Evaluación mediante las redes sociales de la información con la que cuentan los pacientes con EII274283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71468]], camposKey:0213-1463 2017-12-01 INFORMATION AND INTERNET IN INFLAMMATORY BOWEL DISEASE180186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71470]], camposKey:2244-8136 2017-07-01 PERIODONTAL DISEASE AND PRETERM UTERINE CONTRACTIONS HOSPITAL JOSE MARIA BENITEZ. LA VICTORIA, ARAGUA, VENEZUELA128144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71473]], camposKey:1873-9946 2017-02-01 Evolution after a "de-intensification" strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71475]], camposKey:1873-9946 2017-02-01 Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71474]], camposKey:1873-9946 2017-02-01 Serial tuberculin skin test improves the detection of latent tuberculosis infection in inflammatory bowel disease patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71472]], camposKey:1130-0108 2017-01-01 Acute esophageal necrosis resolved in 72 hours2170, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48398]], camposKey:1130-0108 2017-01-01 Acute esophageal necrosis resolved in 72 hours Necrosis aguda de esófago resuelta en 72 horas217218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29398]], camposKey:1130-0108 2017-01-01 Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab122129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56293]], camposKey:1590-8658 2017-01-01 Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment973977, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54546]], camposKey:0002-9270 2017-01-01 Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients12080, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56358]], camposKey:1873-9946 2017-01-01 Early Thiopurine Treatment Is Probably Beneficial but Time From Diagnosis Must Be Evaluated10231023, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56297]], camposKey:1873-9946 2017-01-01 Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory Bowel disease792800, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56298]], camposKey:0002-9270 2017-01-01 Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study120131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56294]], camposKey:0002-9270 2017-01-01 Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry11351143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56296]], camposKey:0210-5705 2017-01-01 Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy Influencia de la experiencia acumulada del explorador en el valor predictivo negativo de la cápsula endoscópica1015, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16981]], camposKey:0210-5705 2017-01-01 Influencia de la experiencia acumulada del explorador en el valor predictivo negativo de la cápsula endoscópica1015, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29397]], camposKey:1130-0108 2017-01-01 Necrosis aguda de esófago resuelta en 72 horas2170, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56362]], camposKey:0013-726X 2017-01-01 Repercusión del sangrado activo detectado mediante cápsula endoscópica11291194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56295]], camposKey:1130-0108 2017-01-01 The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire Las preocupaciones de los pacientes españoles con enfermedad inflamatoria intestinal medidas con el cuestionario RFIPC196201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56292]], camposKey:0210-5705 2017-01-01 Tuberculosis, one more consideration in the differential diagnosis of a pancreatic mass Tuberculosis, un diagnóstico más a tener en cuenta ante una masa pancreática619621, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17364]], camposKey:0210-5705 2017-01-01 Tuberculosis, un diagnóstico más a tener en cuenta ante una masa pancreática619621, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56364]], camposKey:0013-726X 2017-01-01 Utilidad de la repetición de la cápsula endoscópica11291194, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71477]], camposKey:1083-4389 2016-09-01 Pan-European Registry on Helicobacter pylori Management (Hp-EuReg): Interim analysis of the single-capsule bismuth quadruple treatment (Pylera (R))7374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71476]], camposKey:0016-5085 2016-04-01 European Registry on H. pylori Management (HP-EuReg) in Spain: Interim Analysis in First and Second Line Therapies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71479]], camposKey:1873-9946 2016-03-01 Are relatives aware of inflammatory bowel disease patients' worries?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71478]], camposKey:1873-9946 2016-03-01 Long-term safety of in utero exposure to anti-TNF alpha drugs for the treatment of inflammatory bowel diseases (IBD): Interim results of the TEDDY study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52756]], camposKey:2352-345X 2016-01-01 Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon2239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56303]], camposKey:0269-2813 2016-01-01 Current concepts on microscopic colitis: Evidence-based statements and recommendations of the Spanish Microscopic Colitis Group400426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3281]], camposKey:0002-9270 2016-01-01 Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients14561465, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56301]], camposKey:0210-5705 2016-01-01 Ileocolic fistulas after radiotherapy for endometrial carcinoma Fístulas ileocólicas tras radioterapia por carcinoma de endometrio2324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56299]], camposKey:1078-0998 2016-01-01 Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study894901, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56302]], camposKey:0036-5521 2016-01-01 Infliximab in ulcerative colitis: Real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)186195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54545]], camposKey:0210-5705 2016-01-01 Pruebas de provocación controladas en el diagnóstico diferencial de la enfermedad celíaca2728, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56300]], camposKey:0036-5521 2016-01-01 The utility of faecal calprotectin to predict post-operative recurrence in Crohn's disease720726, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71482]], camposKey:1130-0108 2015-09-01 Pitavastatin: another statin to use and to monitor576577, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71483]], camposKey:0016-5085 2015-04-01 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71484]], camposKey:0016-5085 2015-04-01 Extracolonic Neoplasias in Inflammatory Bowel Disease Patients: Data From the GETECCU Eneida Registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71488]], camposKey:1873-9946 2015-02-01 Evolution after anti-TNF drug discontinuation in patients with inflammatory bowel disease (IBD): a multicenter long-term follow-up study.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71489]], camposKey:1873-9946 2015-02-01 Extracolonic neoplasias in Inflammatory Bowel Disease patients: Data from the GETECCU ENEIDA registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71491]], camposKey:1873-9946 2015-02-01 Performance of Tuberculin skin test in routine screening for latent tuberculosis infection in patients with inflammatory bowel diseases00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71487]], camposKey:1873-9946 2015-02-01 Predictors of bad response to infliximab in Ulcerative Colitis patients (ECIA study. ACAD)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71490]], camposKey:1873-9946 2015-02-01 Worries in IBD patient relatives. Why and how much do they worry?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39637]], camposKey:1078-0998 2015-01-01 Are Worries and Concerns Information Side Effects?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56306]], camposKey:1130-0108 2015-01-01 Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis Frecuencia, factores predictores y consecuencias de la intensificación del tratamiento de mantenimiento con infliximab en la colitis ulcerosa527533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56365]], camposKey:0016-5085 2015-01-01 H. pylori Second-Line Rescue Therapy With Levofloxacin and Bismuth After Failure of Standard Triple or Non-Bismuth Quadruple Treatment00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56308]], camposKey:0269-2813 2015-01-01 Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments768775, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3284]], camposKey:2234-943X 2015-01-01 Human colon-derived soluble factors modulate gut microbiota composition00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=5725]], camposKey:2072-6643 2015-01-01 Increased intraepithelial V alpha24 invariant NKT cells in the celiac duodenum.89608976, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56305]], camposKey:1130-0108 2015-01-01 Pitavastatin: Other statin to be used and monitored Pitavastatina: Otra estatina a emplear y vigilar576577, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56307]], camposKey:1078-0998 2015-01-01 Resources utilization and costs the year before and after starting treatment with adalimumab in Crohn's disease patients16311640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2851]], camposKey:0019-2805 2014-10-01 Dendritic cell compartmentalization through the human colon67, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71493]], camposKey:1083-4389 2014-09-01 EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): SPANISH DETAILED RESULTS (INTERIM ANALYSIS)130130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71492]], camposKey:1083-4389 2014-09-01 SECOND-LINE RESCUE THERAPY WITH LEVOFLOXACIN AND BISMUTH AFTER FAILURE OF A HELICOBACTER PYLORI ERADICATION TREATMENT135135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71480]], camposKey:0016-5085 2014-05-01 European Registry on H-pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71481]], camposKey:0016-5085 2014-05-01 Phenotypic Characteristics and Use of Therapeutic Resources in Elderly-Onset Inflammatory Bowel Disease: A Multicentre, Case-Control Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71485]], camposKey:1873-9946 2014-02-01 Infliximab optimisation in ulcerative colitis: Intensificated and deintensificated patients clinical outcome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71486]], camposKey:1873-9946 2014-02-01 Infliximab use in ulcerative colitis from 2003 to 2013: Clinical practice, safety and efficacy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2872]], camposKey:1613-4125 2014-01-01 Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp11321143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56310]], camposKey:0210-5705 2014-01-01 Annular pancreas: A potentially overlooked congenital pancreatic anomaly Páncreas anular: Malformación que puede pasar desapercibida596597, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56311]], camposKey:0016-5107 2014-01-01 EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)342344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22426]], camposKey:0210-5705 2014-01-01 Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56312]], camposKey:1873-9946 2014-01-01 Risk of colectomy in patients with ulcerative colitis under thiopurine treatment12871293, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56309]], camposKey:0210-5705 2014-01-01 Synchronic MALT lymphoma and carcinoid tumor of the ileum Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71494]], camposKey:1352-4585 2013-10-01 Quantifying the physical activity amount in non-disabled multiple sclerosis patients: a starting point for future studies314315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42079]], camposKey:0179-1958 2013-01-01 Atmospheric pressure does not influence acute diverticular disease17251726, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56314]], camposKey:0036-5521 2013-01-01 Crohn's disease diagnosis during adalimumab treatment254255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2866]], camposKey:1932-6203 2013-01-01 Detection of Specific IgA Antibodies against a Novel Deamidated 8-Mer Gliadin Peptide in Blood Plasma Samples from Celiac Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56315]], camposKey:1873-9946 2013-01-01 Differential diagnosis and management of histologic eosinophilic colitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29393]], camposKey:0210-5705 2013-01-01 Divertículo de Meckel y enterolitos como complicación de la enfermedad de Crohn2629, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2845]], camposKey:0019-2805 2013-01-01 Increased cytokine milieu, IgA, intraepithelial lymphocytes and CD103(-) mature DC in the human right colon compared with its left paired counterpart3939, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56316]], camposKey:0210-5705 2013-01-01 Meckel's diverticulum and enteroliths complicating Crohn's disease Divertículo de Meckel y enterolitos como complicación de la enfermedad de Crohn2629, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51036]], camposKey:1328-8067 2013-01-01 Natural history of irritable bowel syndrome204207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56313]], camposKey:0002-9270 2013-01-01 No increase in epstein-barr virus viral load in a group of 30 asymptomatic patients with crohn's disease19331935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42081]], camposKey:0163-2116 2012-01-01 Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding18801886, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2862]], camposKey:0301-0546 2012-01-01 Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients38, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56320]], camposKey:1130-0108 2012-01-01 Gastric metastasis from renal cell carcinoma.334335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2864]], camposKey:0014-2980 2012-01-01 IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate13371353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56319]], camposKey:1130-0108 2012-01-01 Predictable bad evolution of an acute pancreatitis?103104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56317]], camposKey:1130-0108 2012-01-01 Questions and similarities between Crohn's disease and Henoch-Schönlein Dudas y similitudes entre la enfermedad de Crohn y la púrpura de Henoch-Schönlein222223, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56318]], camposKey:1130-0108 2012-01-01 Radiation enteritis: Diagnosis by intestinal capsule Enteritis por radiación: Diagnóstico por cápsula intestinal212213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56322]], camposKey:1130-0108 2011-01-01 Autoimmune pancreatitis: Response to steroids as a means of diagnosis Pancreatitis autoinmune: Respuesta a esteroides como vía de diagnóstico159160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56321]], camposKey:0001-6519 2011-01-01 Hamartomatous polyp of the hypopharynx Pólipo hamartomatoso de la hipofaringe472474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2852]], camposKey:0036-5521 2011-01-01 IFN beta 1b induced celiac disease15251526, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2830]], camposKey:0019-2805 2011-01-01 Intestinal homeostatic signals are lost in affected areas of ulcerative colitis patients inducing an abnormal skin homing phenotype in dendritic cells and T-cells they stimulate144144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56323]], camposKey:1130-0108 2011-01-01 Nodular colonic lesion in a nephrectomized patient591591, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2820]], camposKey:1130-0108 2011-01-01 NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid500500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3286]], camposKey:1130-0108 2011-01-01 NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in valladolid5000, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39642]], camposKey:0036-5521 2011-01-01 Percutaneous liver biopsy: patients' point of view727731, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56324]], camposKey:0210-5705 2011-01-01 Primary prophylaxis of post-polylipectomy bleeding with clips Profilaxis primaria de la hemorragia pospolipectomía con clips5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16965]], camposKey:0210-5705 2011-01-01 Profilaxis primaria de la hemorragia pospolipectomía con clips5758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56325]], camposKey:1130-0108 2010-01-01 Another multiple gastric anisakiasis case00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71497]], camposKey:1130-0108 2010-01-01 Another multiple gastric anisakiasis case6061, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39645]], camposKey:1521-6616 2010-01-01 The simultaneous high expression of V alpha 24, IFN-gamma and FoxP3 characterizes the liver of children with type I autoimmune hepatitis396405, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71496]], camposKey:1130-0108 2009-11-01 Abdominal mass, multiple lymphadenopathies, and polyposis800802, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71495]], camposKey:1130-0108 2009-11-01 Presacral mass as a cause of constipation803805, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71499]], camposKey:1130-0108 2009-06-01 Visceral leishmaniasis diagnosed by duodenal biopsy439440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71501]], camposKey:1130-0108 2009-05-01 Efficacy of thalidomide in digestive bleeding caused by angiodysplasias371371, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71500]], camposKey:1130-0108 2009-05-01 Esophageal actinomycosis372373, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71498]], camposKey:1130-0108 2009-03-01 Relapsing colitis cystica profunda226227, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56328]], camposKey:1130-0108 2009-01-01 Abdominal mass, multiple lymphadenopathies, and polyposis Masa abdominal, adenopatías múltiples y poliposis801802, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56329]], camposKey:1130-0108 2009-01-01 Efficacy of thalidomide in digestive bleeding caused by angiodysplasias Eficacia de la talidomida en la hemorragia digestiva por angiodisplasias370371, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56330]], camposKey:1130-0108 2009-01-01 Esophageal actinomycosis Actinomicosis esofágica00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2855]], camposKey:0962-9351 2009-01-01 High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2871]], camposKey:0017-5749 2009-01-01 Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa886887, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56331]], camposKey:1130-0108 2009-01-01 Presacral mass as a cause of constipation Masa presacra como causa de estreñimiento804805, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56327]], camposKey:1130-0108 2009-01-01 Relapsing colitis cystica profunda Colitis quística profunda recidivante226227, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2849]], camposKey:0105-4538 2009-01-01 The profile of gliadin-degrading activity of duodenal mucosa points to a role of microflora in celiac disease366366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56326]], camposKey:1130-0108 2009-01-01 Visceral leishmaniasis diagnosed by duodenal biopsy Leishmaniasis visceral diagnosticada por biopsia duodenal439440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71436]], camposKey:1130-0108 2008-05-01 Submucosal tumor at the bottom of the cecum296297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3307]], camposKey:1177-3928 2008-01-01 Cytokine, chemokine and immune activation pathway profiles in celiac disease: An immune system activity screening by expression macroarrays00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39629]], camposKey:1130-0108 2008-01-01 Diagnostic problems in adult celiac disease2428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56334]], camposKey:1130-0108 2008-01-01 Diagnostic problems in adult celiac disease Problemas diagnósticos en la enfermedad celiaca del adulto2428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2861]], camposKey:0009-9104 2008-01-01 Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients6473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16967]], camposKey:0210-5705 2008-01-01 Peritonitis bacteriana espontánea por Gemella morbillorum en un paciente en tratamiento crónico con norfloxacino129130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56333]], camposKey:0210-5705 2008-01-01 Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin Peritonitis bacteriana espontánea por Gemella morbillorum en un paciente en tratamiento crónico con norfloxacino129129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56332]], camposKey:1130-0108 2008-01-01 Submucosal tumor at the bottom of cecum Tumor submucoso en el fondo del ciego296297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16970]], camposKey:0210-5705 2007-01-01 Divertículo de Meckel y tumor estromal gastrointestinal: una curiosa asociación534537, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54659]], camposKey:0210-5705 2007-01-01 Elevated transaminase levels in adult celiac disease [2] [Elevación de las transaminasas en la enfermedad celíaca del adulto]101102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71438]], camposKey:1130-0108 2007-01-01 Gastrointestinal stromal tumors (GIST): clinical aspects1924, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56336]], camposKey:1130-0108 2007-01-01 Gastrointestinal stromal tumors (GIST): Clinical aspects Tumores de la estroma gastrointestinal (GIST): Aspectos clínicos1924, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2856]], camposKey:0017-5749 2007-01-01 Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides889890, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56335]], camposKey:0210-5705 2007-01-01 Meckel's diverticulum and gastrointestinal stromal tumor: An unusual association Divertículo de Meckel y tumor estromal gastrointestinal: Una curiosa asociación534537, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=16968]], camposKey:0210-5705 2006-01-01 Colitis ulcerosa y anemia hemolítica autoinmunitaria1100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=2836]], camposKey:0009-9104 2006-01-01 Interleukin 18 maintains a long-standing inflammation in coeliac disease patients479485, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56337]], camposKey:0014-2565 2006-01-01 Respiratory insufficiency, vomiting and diarrhea in a Down's syndrome patient Insuficiencia respiratoria, vómitos y diarrea en paciente con síndrome de Down519520, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56338]], camposKey:0210-5705 2006-01-01 Ulcerative colitis and autoimmune hemolytic anemia Colitis ulcerosa y anemia hemolítica autoinmunitaria110110, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71461]], camposKey:0140-1971 2005-08-01 Adolescents' experience with sex on the web: results from online focus groups535540, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56339]], camposKey:1130-0108 2005-01-01 Fistulizing hydatid cyst in the colon [1] Quiste hidatídico fistulizado al colon673674, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71469]], camposKey:0956-4624 2005-01-01 Gay men who attend sex resorts: a typology associated with high-risk sexual behaviour158162, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3311]], camposKey:0301-0546 2005-01-01 IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: Differences between DQ2 positive and negative patients245249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56340]], camposKey:0210-5705 2005-01-01 Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver Hígado graso no alcohólico, índices séricos de hierro y concentración hepática de hierro364364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56341]], camposKey:0210-5705 2005-01-01 Study of gastrointestinal transit times with capsule endoscopy Estudio de los tiempos de tránsito gastrointestinal con cápsula endoscópica315320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71471]], camposKey:1130-0108 2004-12-01 Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C818823, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56342]], camposKey:0149-5992 2004-01-01 Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis20572066, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56344]], camposKey:0014-2565 2004-01-01 Colonic polyps: Dysplasia predictive factors Pólipos de colon: Factores predictivos de displasia251254, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38225]], camposKey:1130-0108 2004-01-01 Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C Sobrecarga de hierro y genotipo 3 se asocian a la presencia de esteatosis en la hepatitis C818828, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56343]], camposKey:0210-5705 2004-01-01 Octreotide and angiodysplasia Octreotida y angiodisplasia558559, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56345]], camposKey:0025-7753 2003-01-01 Hepatotoxicity induced by terazosin Hepatotoxicidad por terazosina118118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56348]], camposKey:0210-5705 2002-01-01 Endoscopic appearance of the duodenal bulb in adult celiac disease Aspecto endoscópico del bulbo duodenal en la enfermedad celíaca del adulto433433, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56347]], camposKey:0210-5705 2002-01-01 Lymphadenomegaly or papillar process ¿linfadenomegalia o proceso papilar?482482, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56346]], camposKey:1130-0108 2002-01-01 Triple pylorus or double antroduodenal fistula [2]501502, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71502]], camposKey:1130-0108 2001-02-01 About the incidence and pathogenesis of acute pancreatitis in Crohn's disease129130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56349]], camposKey:1130-0108 2001-01-01 Incidence and pathogenesis of acute pancreatitis in Crohn disease Sobre la incidencia y la patogenia de la pancreatitis aguda en la enfermedad de Crohn.129130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71443]], camposKey:0191-2917 2000-07-01 Other natural hosts of Potato virus T736738, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71451]], camposKey:1130-0108 2000-05-01 Amoebiasis and inflammatory bowel disease357358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56350]], camposKey:1130-0108 2000-01-01 Amebiasis and intestinal inflammatory disease Amebiasis y enfermedad inflamatoria intestinal.357358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56351]], camposKey:0212-7199 2000-01-01 Solid liver mass. Studies with nuclear medicine Masa hepática sólida. Estudios de Medicina Nuclear.201203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71503]], camposKey:0017-5749 1999-09-01 H. pylori-negative duodenal ulcers prevalence and causes in 774 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71511]], camposKey:0016-5085 1999-04-01 C-13-urea breath test for the diagnosis of H-pylori infection: Is citric acid necessary?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71510]], camposKey:0016-5085 1999-04-01 H-pylori-negative duodenal ulcers. Prevalence and causes in 774 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56353]], camposKey:1130-0108 1999-01-01 Alteraciones del metabolismo del hierro en la hepatitis crónica C583589, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56352]], camposKey:0212-7199 1999-01-01 Endoscopy in celiac disease Endoscopia en la enfermedad celíaca.547548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56355]], camposKey:0163-2116 1999-01-01 H. pylori-negative duodenal ulcer prevalence and causes in 774 patients22952302, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56354]], camposKey:0014-2565 1999-01-01 Pericholangitis and primary sclerosing cholangitis Pericolangitis y colangitis esclerosante primaria.258259, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71508]], camposKey:0016-5085 1998-04-15 Associated endoscopic findings in Mallory Weiss Syndrome.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71506]], camposKey:0016-5085 1998-04-15 Associated factors and causes of Mallory Weiss Syndrome.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71505]], camposKey:0016-5085 1998-04-15 Intestinal methanogenic flora and Helicobacter pylori infection.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71504]], camposKey:0016-5085 1998-04-15 Is it necessary to take biopsies in upper gastrointestinal endoscopy in patients with HIV infection?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71507]], camposKey:0016-5085 1998-04-15 Long-term follow up of Mallory Weiss Syndrome.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56356]], camposKey:0014-2565 1998-01-01 Ectasia vascular antral: Aspectos etiopatogénicos, clínicos y terapéuticos369375, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71509]], camposKey:0017-5749 1997-10-01 Does Helicobacter pylori play a role in hydrogen (H2) or methane (CH4) basal production?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71437]], camposKey:0017-5749 1997-09-01 Direct correlation between the C-13-urea breath test values and the density of Helicobacter pylori in antrum biopsies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71512]], camposKey:0017-5749 1997-09-01 What to do in patients with C-13-urea breath test values in the 3-5 per mil range?00][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=27882]},camposKey: 179 192 Endoscopia y otros procedimientos diagnósticos 8416270937Enfermedad celíaca 1 2016-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=27883]},camposKey: 67 86 Presentación clínica en el adulto. Enfermedades asociadas. Enfermedad celíaca refractaria 8416270937Enfermedad celíaca 1 2016-01-01 Ergon , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21532]},camposKey: 129 142 Endoscopia y otros procedimientos diagnósticos 978-84-8473-958-6Enfermedad Celíaca. Introducción al conocimiento actual de la Enfermedad celíaca. 2ª edicion 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21533]},camposKey: 47 63 Enfermedad celíaca del adulto 978-84-8473-958-6Enfermedad Celíaca. Introducción al conocimiento actual de la Enfermedad celíaca. 2ª edicion 1 2011-01-01 Ergon, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=29246]},camposKey: 143 156 Protocolos de diagnóstico: cribado de enfermedad celíaca y grupos de riesgo 8484739589Enfermedad celíaca 1 2011-01-01 Ergon][com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=340]]][][][][][][][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=298]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=299]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=300]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=301]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=302]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=310]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=305]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=309]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=306]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=307]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=308]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=298]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=299]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=300]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=301]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=302]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=310]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=305]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=309]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=306]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=307]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=308]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639496]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636136]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639376]]][][][][][][com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=628]]][GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=263 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=264 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=80 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=78 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=79 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=74 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=77 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=76 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=73 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=75 ] ], GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=72 ] ]][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5fbbfb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5fbb26, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5fb57c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5fb0e2][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4662e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131c2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412f0b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125b3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4138a8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125e9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412b67]][][][][][IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=197 ] ], IftpertinEntitats[ iftpertinEntitatsPK=IftpertinEntitatsPK[ ifcactivitat=PEC, ifccomptador=196 ] ]][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13bf7, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13bf2][]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (243)

Perez-Aisa A.; Nyssen O.P.; Keco-Huerga A.; Rodrigo L.; Lucendo A.J.; Gomez-Rodriguez B.J.; Ortuño J.; Perona M.; Huguet J.M.; Nuñez O.; Fernandez-Salazar L.; Barrio J.; Lanas A.; Iyo E.; Romero P.M.; Fernandez-Bermejo M.; Gomez B.; Garre A.; Gomez-Camarero J.; Lamuela L.J.; Campillo A.; De La Peña-Negro L.; Cajal M.D.; Bujanda L.; Burgos-Santamaria D.; Bermejo F.; Gonzalez-Carrera V.; Pajares R.; Notari P.A.; Tejedor-Tejada J.; Planella M.; Jimenez I.; Lazaro Y.A.; Cuadrado-Lavin A.; Perez-Martinez I.; Amorena E.; Gonzalez-Santiago J.M.; Angueira T.; Flores V.; Martinez-Dominguez S.J.; Pabon-Carrasco M.; Velayos B.; Algaba A.; Ramirez C.; Almajano E.A.; Castro-Fernandez M.; Alcaide N.; Segura P.S.; Cano-Catala A.; Garcia-Morales N.; Moreira L.; Megraud F.; O'Morain C.; Calvet X.; Gisbert J.P. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) . GUT 2023; 72(11): 2031-2037.

Enlace a la publicación
Ver Todos

Capítulos de libros (5)

Fernandez Salazar, Luis Ignacio. Endoscopia y otros procedimientos diagnósticos . En: -. Enfermedad celíaca. Ergon 2016. p. 179-192.


Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (9)

BIOMARCADORES DE PRONOSTICO Y MECANISMOS DE INFLAMACIÓN MEDIANTE CITOMETRÍA DE MASAS Y MULTIPLEX. Equipo Investigadores: BERNARDO ORDIZ, DAVID (IP); ARRANZ SANZ, EDUARDO; GARROTE ADRADOS, JOSE ANTONIO; FERNANDEZ SALAZAR, LUIS IGNACIO. Personal Contratado: CAL SABATER, PALOMA DE LA; PEREZ SEGURADO, CANDIDO; GARCIA BLESA, ANTONIO; PEREZ COZAR, FRANCISCO. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: FONDOS FEDER, MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES, INSTITUTO DE SALUD CARLOS III, JUNTA DE CASTILLA Y LEÓN -CONSEJERÍA DE EDUCACIÓN. 19/06/2020-15/10/2021

FEDERJCYL-1Ministerio de Ciencia, Innovación y UniversidadesInstituto de Salud Carlos III
Ver Todos

Convenios/Contratos OTC (4)

NUEVOS ABORDAJES DE BIG DATA PARA EL ESTUDIO DE LOS MICROORGANISMOS ENTÉRICOS Y SUS RELACIONES EN LA ENFERMEDAD INFLAMATORIA INTESTINAL.. Equipo Investigadores: FERNANDEZ SALAZAR, LUIS IGNACIO (IP); CUESTA SANCHO, SARA (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: MENYCEP SL.. 02/01/2023

Ver Todos
 

OTROS

Tesis doctorales (3)


Texto completo en acceso abierto  
Ver Todos

Premios (11)

Fernández Salazar L; de Pedro Andrés R, Alonso Vicente C, Marugán de Miguelsanz M, Alonso Martín C, Alcaide Suárez N, Antolín Melero B, Escudero Hernández C, Arribas Rodríguez E, Garrote Adrados JA, Arranz Sanz E. . Premio a la mejor comunicación oral en intestino delgado y colon de los Premios FEAD 2019. Sociedad Española de Patología Digestiva. 2019

Ver Todos

Colaboración en revistas (1)

Editor. Revista Española de Enfermedades Digestivas, 2018
Ver Todos

Participación en tribunales (11)

. Tesis doctoral Cristina Laserna Gallegos; SEC. 31/01/2024
Ver Todos

Participación en comités (1)

GERENCIA REGIONAL DE SALUD. JUNTA DE CASTILLA Y LEÓN. Grupo de trabajo de Patología Inflamatoria Intestinal. 30/04/2013
Ver Todos

Entidades científicas (2)

. Vice-Presidente. Des de 22/10/2008
Ver Todos

Proyectos de innovación docente (2)

Digitalización de diapositivas de exploración física del archivo del Hospital Clínico Universitario - PID-2011/92. Universidad de Valladolid. 01/09/2011.
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados